HSV has made an update to Supplementary 013. Please find the updated information as below.

HSV plans to release a tender for the supply of goods listed below:

Subcat no.  Subcat description – list all molecules

14.01       ALCOHOL 70% SOLUTION STERILE, TRIGGER SPRAY, BOTTLE 500 ML

539.01     AMPHOTERICIN B (LIPOSOMAL) 50 MG INJECTION, AMPOULE/VIAL

540.01     ATROPINE 600 MICROG INJECTION, AMPOULE/VIAL

519.01     CABAZITAXEL 60 MG INJECTION, AMPOULE/VIAL

118.02     CYCLIZINE 50 MG INJECTION, AMPOULE/VIAL

541.01     ESMOLOL 100 MG INJECTION, AMPOULE/VIAL

542.01     ETHAMBUTOL 400 MG TABLET

220.09     HYDROCORTISONE SODIUM SUCCINATE 100 MG INJECTION, AMPOULE/VIAL

543.01     ICATIBANT 30 MG INJECTION, SYRINGE

544.01     ISOPRENALINE 1 MG/5 ML INJECTION, AMPOULE/VIAL, 5 ML

545.01     LANREOTIDE 60 MG INJECTION, SYRINGE

545.02     LANREOTIDE 90 MG INJECTION, SYRINGE

545.03     LANREOTIDE 120 MG INJECTION, SYRINGE

330.04     MYCOPHENOLATE MOFETIL 500 MG INJECTION, AMPOULE/VIAL

546.01     NIMODIPINE 10 MG INJECTION, AMPOULE/VIAL

547.01     PLERIXAFOR 24 MG INJECTION, AMPOULE/VIAL

548.01     POTASSIUM CHLORIDE 10 MMOL/10 ML INJECTION, AMPOULE/VIAL

549.01     THIOTEPA 15 MG INJECTION, AMPOULE/VIAL

549.02     THIOTEPA 100 MG INJECTION, AMPOULE/VIAL

487.02     TRIMETHOPRIM/SULFAMETHOXAZOLE 80MG/400 MG INJECTION, AMPOULE/VIAL

496.05     VALPROATE SODIUM 400 MG INJECTION, AMPOULE/VIAL

83001.01  BEVACIZUMAB 100MG/4ML INJECTION, AMPOULE/VIAL, 4ML

83001.02   BEVACIZUMAB 400MG/16ML INJECTION, AMPOULE/VIAL, 16ML